Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02228382
Title Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Recruitment Terminated
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Pfizer
Indications

chronic myeloid leukemia

Therapies

Bosutinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Additional content available in CKB BOOST